Generic substitution does not seem to affect adherence negatively in elderly polypharmacy patients

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 10, 2013, Pages 1093-1098

  Olesen, Charlotte ^a   Harbig, Philipp ^a   Barat, Ishay ^b   Damsgaard, Else Marie ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HORSENS REGIONAL HOSPITAL   (Denmark)

Author keywords

Adherence; Elderly; Generic substitution; Pharmacoepidemiology; Polypharmacy

Indexed keywords

GENERIC DRUG; PRESCRIPTION DRUG;

AGED; ARTICLE; CONTINGENCY TABLE; CONTROLLED STUDY; DENMARK; DRUG SUBSTITUTION; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NATIONAL HEALTH INSURANCE; PHARMACEUTICAL CARE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE DATABASE; SHORT COURSE THERAPY;

ADHERENCE; ELDERLY; GENERIC SUBSTITUTION; PHARMACOEPIDEMIOLOGY; POLYPHARMACY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DENMARK; DRUG SUBSTITUTION; DRUGS, GENERIC; HUMANS; MEDICATION ADHERENCE; POLYPHARMACY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84884984116     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3497     Document Type: Article

References (28)

1. European Medicine Agency. Questions and answers on generic medicines. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/ Medicine_QA/2009/11/WC500012382.pdf [18 April 2013].
2. The European Parliament and the Council of the European Union. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (consolidated version 21/07/2011). Available at: http://ec.europa.eu/health/files/eudralex/vol- 1/dir_2001_83/2001_83_ec_en.pdf [18 April 2013].
3. European Generic Medicines Association. How to increase patient access to generic medicines in European healthcare systems. A report by the EGA Health Economics Committee. Available at: http://www.egagenerics.com/images/ publication/PDF/Market_Barriers_Report_FINAL_update.pdf [18 April 2013].
4. Indenrigs- og Sundhedsministeriet. Bekendtgørelse af lov om apoteksvirksomhed. LBK nr 855 af 04/08/2008; København: ministeriet, 2008.
5. Indenrigs- og Sundhedsministeriet. Lov om ændring af apotekerloven. LOV nr 465 af 18/05/2011. Ministeriet: København, 2011.
6. The Association of Danish Pharmacies. Drugs in Denmark 2011, 2012.
7. Posner J, Griffin JP. Generic substitution. Br J Clin Pharmacol 2011; 72(5): 731-732. DOI:10.1111/j.1365-2125.2011.03920.x.
8. Toverud EL, Roise AK, Hogstad G, Wabo I. Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences. Eur J Clin Pharmacol 2011; 67(1): 33-38. DOI:10.1007/s00228-010-0935-x.
9. Greene JA, Kesselheim AS. Why do the same drugs look different? Pills, trade dress, and public health. N Engl J Med 2011; 365(1): 83-89. DOI:10.1056/NEJMhle1101722.
10. Hakonsen H, Eilertsen M, Borge H, Toverud EL. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin 2009; 25(10): 2515-2521. DOI:10.1185/03007990903192223.
11. World Health Organization. Adherence to long-term therapies: evidence for action. [S.l.]: WHO, 2003.
12. Johnston A, Asmar R, Dahlof B, et al. Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe. Br J Clin Pharmacol 2011; 72(5): 727-730. DOI:10.1111/j.1365-2125.2011.03987.x.
13. Bulsara C, McKenzie A, Sanfilippo F, Holman CD, Emery JE. 'Not the full Monty': a qualitative study of seniors' perceptions of generic medicines in Western Australia. Aust J Prim Health 2010; 16(3): 240-245. DOI:10.1071/PY10006.
14. Ude M, Schuessel K, Quinzler R, Leuner K, Muller WE, Schulz M. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database. J Hypertens 2011; 29(9): 1837-1845. DOI:10.1097/HJH.0b013e32834942be.
15. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother 2006; 40(1): 15-20. DOI:10.1345/aph.1G163.
16. Chapman RH, Benner JS, Girase P, et al. Generic and therapeutic statin switches and disruptions in therapy. Curr Med Res Opin 2009; 25(5): 1247-1260. DOI:10.1185/03007990902876271.
17. Strom O, Landfeldt E. The association between automatic generic substitution and treatment persistence with oral bisphosphonates. Osteoporosis Int 2012; 23(8): 2201-2208.
18. Harbig P. Methods for Improving Compliance with Medicine Intake (MICMI). Available at: www.sites.google.com/site/micmiproject [November 2011].
19. Harbig P, Barat I, Lund Nielsen P, Damsgaard EM. Instantaneous detection of nonadherence: quality, strength, and weakness of an electronic prescription database. Pharmacoepidemiol Drug Saf 2012; 21(3): 323-328. DOI:10.1002/pds.2351.
20. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38(2): 303-312. DOI:10.1345/aph.1D252.
21. Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47(6): 1039-1048. DOI:10.1161/01.HYP.0000222373.59104.3d.
22. Himmel W, Simmenroth-Nayda A, Niebling W, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43(10): 472-479.
23. Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns 2008; 73(2): 377-383. DOI:10.1016/j.pec.2008.07.012.
24. Kjoenniksen I, Lindbaek M, Granas AG. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006; 28(5): 284-289. DOI:10.1007/s11096-006-9043-5.
25. Valles JA, Barreiro M, Cereza G, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy 2003; 65(3): 269-275.
26. Shrank WH, Cadarette SM, Cox E, et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care 2009; 47(3): 319-325. DOI:10.1097/MLR.0b013e31818af850.
27. Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32(7-8): 749-754.
28. Van Wijk BLG, Klungel OH, Heerdink ER, De Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother 2005; 39(2): 319-328.